Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Barinthus Biotherapeutics (BRNS) Other Working Capital Changes (2020 - 2025)

Historic Other Working Capital Changes for Barinthus Biotherapeutics (BRNS) over the last 6 years, with Q3 2025 value amounting to -$504000.0.

  • Barinthus Biotherapeutics' Other Working Capital Changes rose 8275.15% to -$504000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.0 million, marking a year-over-year decrease of 41438.92%. This contributed to the annual value of -$3.6 million for FY2024, which is 6559.09% down from last year.
  • Per Barinthus Biotherapeutics' latest filing, its Other Working Capital Changes stood at -$504000.0 for Q3 2025, which was up 8275.15% from -$495000.0 recorded in Q2 2025.
  • In the past 5 years, Barinthus Biotherapeutics' Other Working Capital Changes registered a high of $6.8 million during Q2 2021, and its lowest value of -$4.1 million during Q1 2023.
  • Over the past 5 years, Barinthus Biotherapeutics' median Other Working Capital Changes value was -$504000.0 (recorded in 2025), while the average stood at -$48894.7.
  • In the last 5 years, Barinthus Biotherapeutics' Other Working Capital Changes soared by 2502222.22% in 2021 and then plummeted by 46485.28% in 2023.
  • Over the past 5 years, Barinthus Biotherapeutics' Other Working Capital Changes (Quarter) stood at -$1.3 million in 2021, then skyrocketed by 38.81% to -$779000.0 in 2022, then skyrocketed by 491.4% to $3.0 million in 2023, then crashed by 151.16% to -$1.6 million in 2024, then surged by 67.69% to -$504000.0 in 2025.
  • Its Other Working Capital Changes stands at -$504000.0 for Q3 2025, versus -$495000.0 for Q2 2025 and -$478000.0 for Q1 2025.